Sight Diagnostics
Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch Disruptive Technologies,…
OurCrowd, the Israeli crowdfunding venture investment platform, today announced the launch of its Pandemic Innovation Fund, with plans to raise a total of $100 million. The money will be invested…
Biotech AI startup Sight Diagnostics gets $27.8M to speed up blood tests
Sight Diagnostics, an Israeli medical devices startup that’s using AI technology to speed up blood testing, has closed a $27.8 million Series C funding round. The company has built a…
Sight Diagnostics starts selling an AI-based diagnostics device for faster blood tests
Sight Diagnostics, an Israeli medical devices startup that’s using computer vision and machine learning technology to speed up blood testing, is launching a point-of-care blood diagnostics system today. It claims the…
